MetLife Investment Management, LLC
Position in CLDX — Celldex Therapeutics, Inc.
CIK 1529735
Whippany, NJ
Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,694,059
+$531,109 QoQ
Shares Held
45,527
+24.2% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#107
of 252 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. CLDX ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in CLDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,694,059 | 45,527 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,162,950 | 36,663 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,005,245 | 37,012 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,009,033 | 39,004 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $793,731 | 39,004 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $707,922 | 39,004 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,001,197 | 39,620 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,268,914 | 37,332 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,381,657 | 37,332 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,333,135 | 31,764 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $954,735 | 24,073 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $662,488 | 24,073 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $816,796 | 24,073 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $853,589 | 23,724 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $1,097,536 | 24,625 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $708,596 | 25,208 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $679,607 | 25,208 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $858,584 | 25,208 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $620,403 | 16,056 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $866,863 | 16,056 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $485,114 | 14,507 | Shares | Defined | 2024-05-17 | |
| No filing history on record for this holder in this stock. | ||||||